Aprea Therapeutics SG&A Expense (Quarterly) Trends

Aprea Therapeutics Inc (APRE)

5.61 -0.12 (-2.09%) USD | NASDAQ | Apr 18, 16:00

5.68 +0.07 (+1.25%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	1.643M
September 30, 2023	1.720M
June 30, 2023	1.699M
March 31, 2023	3.366M
December 31, 2022	2.120M
September 30, 2022	3.083M
June 30, 2022	15.63M
March 31, 2022	3.985M
December 31, 2021	3.366M
September 30, 2021	3.415M
June 30, 2021	3.343M

Date	Value
March 31, 2021	3.426M
December 31, 2020	4.895M
September 30, 2020	3.473M
June 30, 2020	3.787M
March 31, 2020	2.776M
December 31, 2019	3.938M
September 30, 2019	2.308M
June 30, 2019	1.619M
March 31, 2019	0.7293M
December 31, 2018	0.5044M
September 30, 2018	0.6237M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.619M

Minimum

Jun 2019

15.63M

Maximum

Jun 2022

3.663M

Average

3.366M

Median

Mar 2023

SG&A Expense (Quarterly) Benchmarks